DK3514153T3 - Pyrimidinforbindelse og farmaceutisk anvendelse deraf - Google Patents
Pyrimidinforbindelse og farmaceutisk anvendelse deraf Download PDFInfo
- Publication number
- DK3514153T3 DK3514153T3 DK18744290.0T DK18744290T DK3514153T3 DK 3514153 T3 DK3514153 T3 DK 3514153T3 DK 18744290 T DK18744290 T DK 18744290T DK 3514153 T3 DK3514153 T3 DK 3514153T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical use
- pyrimidine compound
- pyrimidine
- compound
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170012766 | 2017-01-26 | ||
| PCT/KR2018/001193 WO2018139903A1 (ko) | 2017-01-26 | 2018-01-26 | 피리미딘 화합물 및 그의 의약 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3514153T3 true DK3514153T3 (da) | 2021-09-27 |
Family
ID=62979563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18744290.0T DK3514153T3 (da) | 2017-01-26 | 2018-01-26 | Pyrimidinforbindelse og farmaceutisk anvendelse deraf |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10280154B2 (da) |
| EP (2) | EP3514153B1 (da) |
| JP (3) | JP6608565B2 (da) |
| KR (1) | KR101954369B1 (da) |
| CN (1) | CN110214138A (da) |
| AR (1) | AR110778A1 (da) |
| AU (1) | AU2018211880B2 (da) |
| CA (1) | CA3050239A1 (da) |
| DK (1) | DK3514153T3 (da) |
| EA (1) | EA039868B1 (da) |
| ES (1) | ES2890668T3 (da) |
| HU (1) | HUE056472T2 (da) |
| IL (2) | IL290745B2 (da) |
| MX (1) | MX378509B (da) |
| PH (1) | PH12019501690A1 (da) |
| PL (1) | PL3514153T3 (da) |
| PT (1) | PT3514153T (da) |
| SA (1) | SA519402288B1 (da) |
| SG (1) | SG11201906435SA (da) |
| TW (1) | TWI810172B (da) |
| WO (1) | WO2018139903A1 (da) |
| ZA (1) | ZA201905020B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI810172B (zh) * | 2017-01-26 | 2023-08-01 | 南韓商韓美藥品股份有限公司 | 嘧啶化合物及包括其的藥學組成物 |
| KR101954370B1 (ko) * | 2018-07-25 | 2019-03-05 | 한미약품 주식회사 | 피리미딘 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물 |
| EP3928780A4 (en) * | 2019-02-22 | 2022-12-07 | Hanmi Pharm. Co., Ltd. | PHARMACEUTICAL COMPOSITION CONTAINING A FLT3 INHIBITOR AND HYPOMETHYLATING AGENT FOR THE TREATMENT OF ACUTE MYELOIC LEUKEMIA |
| BR112021016522A2 (pt) * | 2019-02-22 | 2021-10-26 | Hanmi Pharm. Co., Ltd. | Composição farmacêutica para o tratamento da leucemia mieloide aguda |
| WO2020171649A1 (ko) * | 2019-02-22 | 2020-08-27 | 한미약품 주식회사 | Flt3 저해제 및 iap 길항제를 포함하는 급성 골수성 백혈병의 치료를 위한 약학적 조합물 |
| CN111606889B (zh) * | 2019-02-25 | 2023-03-07 | 上海翰森生物医药科技有限公司 | 4-(1-环丙基-1h-吲哚-3-基)-n-苯基嘧啶-2-胺衍生物的制备方法 |
| EP3991733A4 (en) | 2019-06-27 | 2023-07-05 | Hanmi Pharm. Co., Ltd. | Pharmaceutical composition for treating acute myeloid leukemia, containing flt3 inhibitor and chemotherapeutic agents |
| US12643886B2 (en) | 2021-01-07 | 2026-06-02 | Ontario Institute for Cancer Research (OICR), The Governing Council of the University of Toronto, Sinai Health System | Isoindolinone aminopyrimidine compounds as inhibitors of NUAK kinases, compositions and uses thereof |
| CN116102575B (zh) * | 2021-11-09 | 2025-01-17 | 暨南大学 | 环状2-氨基嘧啶类化合物及其用途 |
| WO2023082052A1 (zh) * | 2021-11-09 | 2023-05-19 | 暨南大学 | 环状2-氨基嘧啶类化合物及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0500492D0 (en) * | 2005-01-11 | 2005-02-16 | Cyclacel Ltd | Compound |
| WO2010042337A1 (en) * | 2008-10-07 | 2010-04-15 | Merck Sharp & Dohme Corp. | Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity |
| CN101723936B (zh) | 2008-10-27 | 2014-01-15 | 上海睿星基因技术有限公司 | 激酶抑制剂及其在药学中的用途 |
| TW201022262A (en) | 2008-10-29 | 2010-06-16 | Astrazeneca Ab | Novel compounds 515 |
| US20110005173A1 (en) * | 2009-07-08 | 2011-01-13 | Kraft Foods Global Brands Llc | Method and Apparatus to Create a Contoured Flow Wrap Package |
| US8435980B2 (en) * | 2009-07-15 | 2013-05-07 | Abbvie Inc. | Pyrrolopyridine inhibitors of kinases |
| UY33539A (es) * | 2010-08-02 | 2012-02-29 | Astrazeneca Ab | Compuestos químicos alk |
| DK3686193T3 (da) | 2011-07-27 | 2022-05-30 | Astrazeneca Ab | 2-(2,4,5-substitueret anilino)pyrimidinforbindelser |
| EP2832734A4 (en) * | 2012-03-28 | 2015-08-26 | Takeda Pharmaceutical | HETEROCYCLIC COMPOUND |
| WO2014155300A2 (en) * | 2013-03-28 | 2014-10-02 | Aurigene Discovery Technologies Limited | Substitued pyrimidine amine derivatives as tak-1 inhibitors |
| MX358346B (es) * | 2014-04-04 | 2018-08-15 | Syros Pharmaceuticals Inc | Inhibidores de la quinasa dependiente de ciclina 7 (cdk7). |
| CN113121575A (zh) * | 2014-08-25 | 2021-07-16 | 四川海思科制药有限公司 | 一种(取代的苯基)(取代的嘧啶)胺基衍生物及其制备方法和药物用途 |
| PE20191108A1 (es) * | 2017-01-17 | 2019-08-26 | Astrazeneca Ab | Inhibidores selectivos de jak1 |
| TWI810172B (zh) | 2017-01-26 | 2023-08-01 | 南韓商韓美藥品股份有限公司 | 嘧啶化合物及包括其的藥學組成物 |
-
2018
- 2018-01-26 TW TW107102879A patent/TWI810172B/zh active
- 2018-01-26 MX MX2019008808A patent/MX378509B/es unknown
- 2018-01-26 CA CA3050239A patent/CA3050239A1/en active Pending
- 2018-01-26 WO PCT/KR2018/001193 patent/WO2018139903A1/ko not_active Ceased
- 2018-01-26 CN CN201880008683.1A patent/CN110214138A/zh active Pending
- 2018-01-26 HU HUE18744290A patent/HUE056472T2/hu unknown
- 2018-01-26 IL IL290745A patent/IL290745B2/en unknown
- 2018-01-26 AR ARP180100179A patent/AR110778A1/es active IP Right Grant
- 2018-01-26 SG SG11201906435SA patent/SG11201906435SA/en unknown
- 2018-01-26 EA EA201991580A patent/EA039868B1/ru unknown
- 2018-01-26 ES ES18744290T patent/ES2890668T3/es active Active
- 2018-01-26 PT PT187442900T patent/PT3514153T/pt unknown
- 2018-01-26 KR KR1020180010226A patent/KR101954369B1/ko active Active
- 2018-01-26 PL PL18744290T patent/PL3514153T3/pl unknown
- 2018-01-26 JP JP2019519419A patent/JP6608565B2/ja active Active
- 2018-01-26 DK DK18744290.0T patent/DK3514153T3/da active
- 2018-01-26 AU AU2018211880A patent/AU2018211880B2/en active Active
- 2018-01-26 EP EP18744290.0A patent/EP3514153B1/en active Active
- 2018-01-26 EP EP20201112.8A patent/EP3789386A1/en not_active Withdrawn
- 2018-09-11 US US16/127,487 patent/US10280154B2/en active Active
- 2018-12-19 US US16/226,070 patent/US10519141B2/en active Active
-
2019
- 2019-07-11 IL IL268010A patent/IL268010B/en unknown
- 2019-07-23 PH PH12019501690A patent/PH12019501690A1/en unknown
- 2019-07-24 SA SA519402288A patent/SA519402288B1/ar unknown
- 2019-07-30 ZA ZA2019/05020A patent/ZA201905020B/en unknown
- 2019-10-23 JP JP2019192510A patent/JP7191799B2/ja active Active
-
2022
- 2022-12-07 JP JP2022195974A patent/JP7684002B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| DK3658557T3 (da) | Tyk2-inhibitorer og anvendelser deraf | |
| DK3565550T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan | |
| DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
| PL3303396T3 (pl) | Przeciwciała przeciwko ox40 i ich zastosowanie | |
| DK3331877T3 (da) | Pyrazolpyrimidinderivat og anvendelser deraf | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| IL290745A (en) | A pyrimidine compound and its pharmaceutical use | |
| DK3603620T3 (da) | Liposomsammensætning og farmaceutisk sammensætning | |
| DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| DK3395801T3 (da) | Arylazolforbindelse og skadedyrsbekæmpelsesmiddel | |
| DK3672948T3 (da) | Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser | |
| DK3621694T3 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
| DK3321279T3 (da) | Exenatidmodificeringsmiddel og anvendelse deraf | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3365321T3 (da) | Solabegron-zwitterion og anvendelser deraf | |
| DK3560925T3 (da) | Hidtil ukendt forbindelse og farmaceutisk acceptabelt salt deraf | |
| DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
| DK3724196T3 (da) | Substituerede azetidindihydrothienopyridiner og anvendelse deraf som phosphodiesterasehæmmere | |
| MA49905A (fr) | Polyesteramines et polyesterquats | |
| DK3280405T3 (da) | Inhibitorer og anvendelser deraf | |
| DK3615502T3 (da) | Terapeutiske forbindelser og fremgangsmåder |